However, RENT3B had a favorable prognosis in three cancer types: blood tumor (DSS: HR = 0.323), ovarian cancer (OS: HR = 0.77), and skin cancer (OS: HR = 0.47). Here, UPF3B is linked to hematopoietic and lymphoid system neoplasm.